Ms Vivian J Tinker, MSW | |
1035 Cheraw St, Bennettsville, SC 29512 | |
(843) 454-0442 | |
(843) 454-0212 |
Full Name | Ms Vivian J Tinker |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 1035 Cheraw St, Bennettsville, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770776494 | NPI | - | NPPES |
405127 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Vivian J Tinker, MSW P.o. Box 918, 1035 Cheraw St, Bennettsville, SC 29512 Ph: (843) 454-0841 | Ms Vivian J Tinker, MSW 1035 Cheraw St, Bennettsville, SC 29512 Ph: (843) 454-0442 |
News Archive
Brazil, Russia, India, China and South Africa are injecting new resources, momentum and innovation into efforts to improve health in the world's poorest countries, according to a report released on the eve of the 2012 BRICS Summit. Coming as many traditional donors reduce or slow their spending, the report explores the expanding influence of the BRICS on global health and development.
Boulder Diagnostics Inc. and the Department of Internal Medicine, Radboud University Nijmegen Medical Centre announced today the entry into a license and collaboration agreement to market the innovative Lyme disease diagnostic test developed at RUNMC.
A new report based on previously unreleased data from the Department of Veterans Affairs paints a distressing portrait of an agency buried helplessly in paperwork - with a claims backlog that has gotten far worse in the past four years.
Queensland stores are directed to refrain from openly displaying cigarettes and other tobacco products. Under laws introduced on Thursday, all retail advertising and promotion of tobacco and other smoking-related products will be banned.
Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.
› Verified 2 days ago